secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2025-02-11T23:59:59+00:00
Accession:  0001493152-25-005948
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Matinas BioPharma director Herbert Conrad resigns due to retirement
-------------------------------------------------------------------

- Herbert Conrad resigned from Board of Directors effective February 6, 2025.
- Conrad also stepped down from Audit and Nominating/Corporate Governance Committees.
- Resignation was not due to any material disagreement or change in company direction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000149315225005948/0001493152-25-005948-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000149315225005948/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-005948

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer